Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Brain metastasis of ovarian cancer after negative second-look laparotomy
1University of Istanbul, Istanbul Medical Faculty, Gynecology and Obstetrics Department, Turkey
*Corresponding Author(s): S. E. Akhan E-mail:
We present a case of ovarian carcinoma that had brain metastasis seven months after having a negative second-look laparotomy and 13 months after the onset of diagnosis. Despite intense multidisciplinary treatment with surgery, chemotherapy and radiotherapy, the patient died seven months after second-look laparotomy.
Ovarian carcinoma; Brain metastasis; Second-look laparotomy
S. E. Akhan,M. lsikoglu,Y. Salihoglu,E. Bengisu,S. Berkman. Brain metastasis of ovarian cancer after negative second-look laparotomy. European Journal of Gynaecological Oncology. 2002. 23(4);330-332.
[1] Sood A. K., Sorosky J. I., Dolan M., Anderson B., Buller R. E.: "Distant metastases in ovarian cancer: association with p53 mutations". Clin. Cancer Res., 1999, 5, 2485.
[2] Hardy J. R., Harvey V. J.: "Cerebral metastases in patients with ovarian cancer treated with chemotherapy". Gynecol. Oneal., 1989,33, 296.
[3] Stein M., Steiner M., Klein B., Beck D., Atad J., Kuten A. et al.: "Involvement of the central nervous system by ovarian carcinoma". Cancer, 1986, 58, 2066.
[4] Dauplat J., Nieberg R. K., Hacker N. F.: "Central nervous system metastases in epithelial ovarian carcinoma". Cancer, 1987, 60, 2559.
[5] Geisler J.P., Geisler H. E.: "Brain metastases in epithelial ovarian carcinoma". Gynecol. Oneal., 1995, 57, 246.
[6] Larson D. M., Copeland L. J.,M oser R. P.,M alone J.M. Jr., Gershenson D. M, Wharton J. T: "Central nervous system metastases in epithelial ovarian carcinoma". Obstet. Gynecol., 1986, 68, 746.
[7] John A. Rock, John D. Thompson (eds).:'Te Linde's Operative Gynecology". Eighth edition. Philadelphia: Lippincott-Raven, 1997, 51, 1557.
[8] Buchsbaum H. J.. Brady M. F., Delgado G. et al.: "Surgical staging of carcinoma of the ovaries". Surg. Gynecol. Obstet., 1989, 169.
[9] LeRoux P. D., Berger M. S., Elliott J.P., Tamimi H.K.: "Cerebral metastases from ovarian carcinoma". Cancer. 1991, 67, 2194.
[10] Deutsch M., Beck D.. Manor D.. Brandes J.: "Metastatic brain tumor following negative second-look operation for ovarian carcinoma". Gynecol. Oneal., 1987, 27, 116.
[11] Suzuki M., Tsukagoshi S.、Ohwada M.,K oumura Y., Sato I.: "A patient with brain metastasis from ovarian cancer who showed complete remission after multidisciplinary treatment". Gynecol Oneal.. 1999., 74,483.
[12] Cormio G.. Gabriele A., Maneo A., Zanetta G.. Bonazzi C.. Landoni F.: "Complete remission of brain metastases from ovarian carcinoma with carboplatin". Eur. J. Obstet. Gynecol. Reprod. Biol.,1998, 78, 91.
[13] Vlasveld L. T., Beynen J. H., Boogerd W., Ten Bokkel Huinink W. W., Rodenhuis S.: "Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic study". Cancer Chemothe1: Pharmacol., 1990, 25, 382.
[14] Heimans J. J.. Vermorken J. B., Wolbers J. G., Eeltink C. M., Meijer O. W., Taphoorn M. J., Beijnen J. H.: "Paclitaxel (Taxol) concentrations in brain tumor tissue". Ann. Oneal., 1994, 5, 951.
[15] Glantz M. J.,C hoy H.,K earns C. M.,M ills P. C., Wahlberg L. U., Zuhowski E. G. et al.: "Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors". Cancer Inst., 1995, 87, 1077.
[16] Thomas H. D., Lind M. J.. Ford J., Bleehen N., Calvert A. H., Boddy A. V.: "Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours". Cancer Chemotha Pharmacol., 2000, 45, 284.
[17] Emerich D. F., Snodgrass P.. Dean R., Agostino M., Hasler B., Pink M. et al.: "Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters". Br. J. Cancer, 1999, 80, 964.
[18] Hardy J. R., Harvey V. J.: ··cerebral metastases in patients with ovarian cancer treated with chemotherapy". Gynecol. Oneal., 1989,33, 296.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Top